Previous close | 1.3800 |
Open | 1.4200 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's range | 1.2935 - 1.4800 |
52-week range | 0.4800 - 2.0000 |
Volume | |
Avg. volume | 222,765 |
Market cap | 13.912M |
Beta (5Y monthly) | 2.04 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Discover key insights from Imunon Inc's Q1 2024 earnings, including financial performance, strategic initiatives in clinical trials, and expert leadership insights.
Imunon, Inc. (NASDAQ:IMNN) Q4 2023 Earnings Call Transcript March 28, 2024 Imunon, Inc. beats earnings expectations. Reported EPS is $-0.52, expectations were $-0.59. Imunon, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning. My name is Dave, and […]